MSR1重复序列调控基因表达并影响乳腺癌与前列腺癌风险
该研究结合生物信息学与实验方法,发现MSR1小卫星重复序列主要位于19号染色体并富集于调控区域,其拷贝数变异可调控基因表达。在KLK14基因内鉴定出MSR1簇,9拷贝等位基因在两个独立人群中与非家族性乳腺癌显著相关,并在另一独立人群中与前列腺癌风险升高相关。
要点
- MSR1重复序列作为分子开关调控基因表达,其拷贝数变异可能影响多种癌症风险。
- KLK14内MSR1簇的9拷贝等位基因与非家族性乳腺癌风险显著相关。
- 9拷贝等位基因亦与前列腺癌风险升高相关,提示MSR1基因分型可用于风险分层。
核心结论
- MSR1重复序列通过拷贝数变异调控基因表达,可能影响乳腺癌和前列腺癌等多种癌症的发生风险。
- KLK14处的MSR1簇是非家族性乳腺癌迄今最强的风险因素,也是前列腺癌的显著风险因素。
研究设计与样本
- 采用生物信息学与实验方法评估MSR1在基因组中的分布、调控潜力及其在癌症中的作用。
- 重点探索非家族性乳腺癌和前列腺癌,关联分析在独立人群中进行验证。
主要发现
- MSR1主要位于19号染色体,功能上富集于短程调控区域(H3K27ac、H3K4me1和H3K4me3)。
- MSR1调控的基因具有特定分子功能,如丝氨酸蛋白酶活性(P = 4.80 × 10-7)和离子通道活性(P = 2.7 × 10-4)。
- KLK14内MSR1簇的9拷贝和11拷贝为正常变异,其中9拷贝等位基因与非家族性乳腺癌相关(两个独立人群P = 0.004;P = 0.03)。
- 在英国白人人群中,次要等位基因使所有非家族性疾病风险增加1.21-3.51倍,早发性疾病风险增加1.7-5.3倍。
- 9拷贝等位基因在独立人群中与前列腺癌风险升高相关(OR = 1.27-1.56;P = 0.009)。
关键数值与推荐
- MSR1主要位于19号染色体,富集于H3K27ac、H3K4me1和H3K4me3调控区域。
- 丝氨酸蛋白酶活性富集P = 4.80 × 10-7,离子通道活性富集P = 2.7 × 10-4。
- KLK14内MSR1簇9拷贝等位基因与非家族性乳腺癌相关:两个独立人群P = 0.004和P = 0.03。
- 英国白人人群中次要等位基因风险增加倍数:所有非家族性疾病1.21-3.51倍,早发性疾病1.7-5.3倍。
- 9拷贝等位基因与前列腺癌风险相关:OR = 1.27-1.56,P = 0.009。
临床怎么用
- MSR1基因分型可能用于非家族性乳腺癌和前列腺癌的精确风险分层。
- MSR1重复序列拷贝数变异可作为新型治疗靶点开发的依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: MSR1 repeats are a 36-38 bp minisatellite element that have recently been implicated in the regulation of gene expression, through copy number variation (CNV). PATIENTS AND METHODS: Bioinformatic and experimental methods were used to assess the distribution of MSR1 across the genome, evaluate the regulatory potential of such elements and explore the role of MSR1 elements in cancer, particularly non-familial breast cancer and prostate cancer. RESULTS: MSR1s are predominately located at chromosome 19 and are functionally enriched in regulatory regions of the genome, particularly regions implicated in short-range regulatory activities (H3K27ac, H3K4me1 and H3K4me3). MSR1-regulated genes were found to have specific molecular roles, such as serine-protease activity (P = 4.80 × 10-7) and ion channel activity (P = 2.7 × 10-4). The kallikrein locus was found to contain a large number of MSR1 clusters, and at least six of these showed CNV. An MSR1 cluster was identified within KLK14, with 9 and 11 copies being normal variants. A significant association with the 9-copy allele and non-familial breast cancer was found in two independent populations (P = 0.004; P = 0.03). In the white British population, the minor allele conferred an increased risk of 1.21-3.51 times for all non-familial disease, or 1.7-5.3 times in early-onset disease. The 9-copy allele was also found to be associated with increased risk of prostate cancer in an independent population (odds ratio = 1.27-1.56; P =0.009). CONCLUSIONS: MSR1 repeats act as molecular switches that modulate gene expression. It is likely that CNV of MSR1 will affect risk of development of various forms of cancer, including that of breast and prostate. The MSR1 cluster at KLK14 represents the strongest risk factor identified to date in non-familial breast cancer and a significant risk factor for prostate cancer. Analysis of MSR1 genotype will allow development of precise stratification of disease risk and provide a novel target for therapeutic agents.
引用
- Rose AM, Krishan A, Chakarova CF, et al. MSR1 repeats modulate gene expression and affect risk of breast and prostate cancer. Ann Oncol. 2018. PMID: 29509840. doi:10.1093/annonc/mdy082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。